Linda Burkly
Chief Scientific Officer
Other
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Editas Medicine, Inc. (EDIT) | Executive Vice President and Chief Scientific Officer | $517,169 | $1,176,389 |
| 2023 | Editas Medicine, Inc. (EDIT) | Executive Vice President and Chief Scientific Officer | $209,423 | $1,537,048 |
Earnings-call appearances
-
Editas Medicine, Inc. Q2 FY2024 Earnings Call2024-08-07
Editas Medicine, Inc. (EDIT)
-
Editas Medicine, Inc. Q1 FY2024 Earnings Call2024-05-08
Editas Medicine, Inc. (EDIT)
-
Editas Medicine, Inc. Q3 FY2023 Earnings Call2023-11-03
Editas Medicine, Inc. (EDIT)